# Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism

> **NCT00196027** · NA · UNKNOWN · sponsor: **Cierra** · enrollment: 40 (—)

## Conditions studied

- Patent Foramen Ovale

## Interventions

- **DEVICE:** PFX Closure System

## Key facts

- **NCT ID:** NCT00196027
- **Lead sponsor:** Cierra
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196027, "Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00196027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*